This story examines how research that shows that certain cannabinoid compounds can block Covid-19 infections in human cells may eventually lead to new drug treatments. However there are many scientific, medical, regulatory and marketing hurdles to pass before that can happen.

Meanwhile and separately, cannabinoids’ anti-inflamatory properties may also point the way to other Covid-19 treatments.

I'm already a subscriber
Author default picture

CannIntelligence

Staff member
CannIntelligence contributor.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization